Replication-Competent Viruses as Cancer Immunotherapeutics: Emerging Clinical Data

Replication-competent (oncolytic) viruses (OV) as cancer immunotherapeutics have gained an increasing level of attention over the last few years while the clinical evidence of virus-mediated antitumor immune responses is still anecdotal. Multiple clinical studies are currently ongoing and more immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Zamarin, Dmitriy, Pesonen, Sari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968310/
https://www.ncbi.nlm.nih.gov/pubmed/26176173
http://dx.doi.org/10.1089/hum.2015.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968310/
https://www.ncbi.nlm.nih.gov/pubmed/26176173
http://dx.doi.org/10.1089/hum.2015.055

Ejemplares similares